SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SSgA Active Trust - SPDR S&P 500 ETF Trust

SPY is trending amidst escalating geopolitical tensions, primarily driven by fresh tariff threats from the US administration against European allies, particularly in light of controversial rhetoric regarding Greenland. This has ignited a sharp division among investors, with many anticipating a significant market pullback, while others strongly believe in a swift "buy the dip" recovery, further complicated by discussions around the Japan bond market's stability.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

QQQ is trending as escalating geopolitical tensions, fueled by threats of tariffs and a looming Supreme Court decision on trade policy, generate significant market uncertainty. Community sentiment is sharply divided between those predicting a substantial market downturn due to political instability and those advocating to "buy the dip," expecting resilience from tech and growth stocks.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending following Saudi Arabia's approval of its Anktiva-based Bioshield protocol for non-small cell lung cancer and broader cancer treatment, alongside ongoing discussions with the FDA for papillary bladder cancer. The community is passionately discussing the potential for a significant short squeeze, viewing the company as a disruptive force in oncology while expressing strong frustration with perceived FDA delays.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group Corp. (DJT) is trending amidst intense debate spurred by former President Trump's controversial push for tariffs against European nations, reportedly tied to his interest in Greenland and past grievances. This situation has ignited polarized community discussions concerning potential trade wars and geopolitical repercussions, with many weighing economic stability against his "America First" agenda.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is a prominent trending topic, experiencing pre-market declines amid broader market volatility and geopolitical trade tensions. The community is actively debating a potential "red to green" recovery, with bulls "buying the dip" while bears highlight growing competition from international EV brands and express skepticism about the company's ambitious AI and robotics initiatives. This discussion occurs as the market anticipates upcoming earnings and recent news regarding the company's accelerated AI chip development.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is trending as investors react to confirmed ongoing collaboration with Celestial AI, now acquired by Marvell, validating POET's pivotal role in next-gen AI optical interconnects. The community is buzzing about the company's patented Optical Interposer and its passive alignment technology, which enables highly efficient wafer-scale optical transceiver assembly for AI data centers. Anticipation is high for upcoming customer announcements and the imminent disclosure of fundamental investors, despite ongoing market manipulation concerns.

BlackRock Institutional Trust Company N.A. - iShares Russell 2000 ETF

iShares Russell 2000 ETF

The iShares Russell 2000 ETF (IWM) is a central topic amidst escalating trade tensions regarding potential US tariffs on EU goods, stemming from geopolitical demands, and an awaited Supreme Court ruling on existing tariffs. Despite this policy uncertainty, IWM is displaying remarkable relative strength, consistently reaching new highs and outperforming large-cap indices. This robust small-cap performance is prompting community debate, with some viewing it as a healthy market rotation and broadening of growth, while others express caution regarding the profitability of some underlying companies.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

AppLovin (APP) is trending following an investigative report alleging the company's involvement in money laundering for a Southeast Asian gambling group, which has sparked a sharp market sell-off. While some in the community are expressing serious concerns and anticipating further declines, many long-term investors are dismissing the report as a rehashed short attack and are actively buying the dip, expecting a strong rebound following upcoming earnings and management's anticipated defense of the allegations.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals Corp. (CRML) is drawing significant market attention amidst escalating geopolitical discussions surrounding Greenland's vast critical mineral resources and the strategic imperative to secure rare earth supply chains. Community discussion is buzzing around the company's established partnerships for rare earth processing and expectations for updates from a highly anticipated business call, all set against a backdrop of increasing global demand for strategic metals.

Venture Global, Inc. engages in the development and construction of liquefied natural gas production, establishing us as a rapidly growing company delivering critical LNG to the world. It projects include Calcasieu, Plaquemines, CP2, CP3 and Delta projects. The company was founded by Michael Sabel and Robert Pender in 2023 and is headquartered in Arlington, VA.

Venture Global Inc. - Ordinary Shares - Class A

Venture Global Inc

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Mineralys Therapeutics (NASDAQ:MLYS) Insider David Malcom Rodman Sells 7,709 Shares

Mineralys Therapeutics, Inc. (NASDAQ:MLYS - Get Free Report) insider David Malcom Rodman sold 7,709 shares of the business's stock in a transaction on Tuesday, January 13th. The shares were sold at...

Insider Selling: Mineralys Therapeutics (NASDAQ:MLYS) Insider Sells 7,709 Shares of Stock

Mineralys Therapeutics, Inc. (NASDAQ:MLYS - Get Free Report) insider David Malcom Rodman sold 7,709 shares of Mineralys Therapeutics stock in a transaction dated Tuesday, January 13th. The shares...

David Malcom Rodman Sells 11,367 Shares of Mineralys Therapeutics (NASDAQ:MLYS) Stock

Mineralys Therapeutics, Inc. (NASDAQ:MLYS - Get Free Report) insider David Malcom Rodman sold 11,367 shares of Mineralys Therapeutics stock in a transaction dated Wednesday, January 14th. The shares...

Mineralys Therapeutics (NASDAQ:MLYS) Shares Down 7% - Here's What Happened

Mineralys Therapeutics (NASDAQ:MLYS) Stock Price Down 7% - Time to Sell...

Insider Selling: Mineralys Therapeutics (NASDAQ:MLYS) Insider Sells 70,037 Shares of Stock

Mineralys Therapeutics, Inc. (NASDAQ:MLYS - Get Free Report) insider David Malcom Rodman sold 70,037 shares of the stock in a transaction dated Friday, January 2nd. The stock was sold at an average...

Mineralys Therapeutics (NASDAQ:MLYS) Insider Sells $6,748,879.30 in Stock

Mineralys Therapeutics, Inc. (NASDAQ:MLYS - Get Free Report) insider David Malcom Rodman sold 192,715 shares of the business's stock in a transaction on Monday, January 5th. The shares were sold at...

Mineralys Therapeutics, Inc. (NASDAQ:MLYS) Given Average Recommendation of "Moderate Buy" by Brokerages

Mineralys Therapeutics, Inc. (NASDAQ:MLYS - Get Free Report) has earned a consensus rating of "Moderate Buy" from the eight brokerages that are covering the company, MarketBeat reports. One...

Mineralys Therapeutics (NASDAQ:MLYS) Stock Price Down 3.4% - What's Next?

Mineralys Therapeutics (NASDAQ:MLYS) Stock Price Down 3.4% - What's Next...

Simplify Asset Management Inc. Takes Position in Mineralys Therapeutics, Inc. $MLYS

Simplify Asset Management Inc. bought a new stake in Mineralys Therapeutics, Inc. (NASDAQ:MLYS - Free Report) in the 3rd quarter, according to its most recent filing with the SEC. The fund bought...

Swedbank AB Sells 84,500 Shares of Mineralys Therapeutics, Inc. $MLYS

Swedbank AB trimmed its stake in shares of Mineralys Therapeutics, Inc. (NASDAQ:MLYS - Free Report) by 22.0% during the third quarter, according to the company in its most recent 13F filing with the...

Mineralys Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing medicines to target diseases driven by abnormally elevated aldosterone. Its clinical-stage product candidate, lorundrostat, is a proprietary, orally administered, highly selective aldosterone synthase inhibitor that are initially developing for the treatment of cardiorenal conditions affected by abnormally elevated aldosterone, including hypertension and chronic kidney disease. The company was founded by Brian Taylor Slingsby on May 31, 2019 and is headquartered in Radnor, PA.

MLYS
Mineralys Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest MLYS News

MLYSMineralys Therapeutics Inc